References

  1. Neil HA, Gatling W, Mather HM, Thompson AV, Thorogood M, Fowler GH, Hill RD, Mann JI. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med. 1987 Nov-Dec;4(6):539-43. This article on PubMed

  2. Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J. 1997 May;74(5):299-302. This article on PubMed

  3. UK Prospective Diabetes Study Group Prospective Diabetes Study IV. Characteristics of newly presenting type 2 diabetic patients: male preponderance and obesity at different ages - Multicenter Study. Diabetic Medicine. 1988; 5: 154-159. This article on PubMed

  4. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int. 1999 Jan;55(1):308-14. This article on PubMed

  5. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 1995 Sep;44(9):1054-8. This article on PubMed

  6. von Eckardstein A, Assmann G. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997 Nov 27;337(22):1632-3. This article on PubMed

  7. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974 Sep 12;291(11):537-43. This article on PubMed

  8. Carson NAJ, Neil DW. Metabolic abnormalies deteccted in a survey of mentally backward individuals in Northen Irelnd. Arch Dis Child. 1962; 37: 505-513. This article on PubMed

  9. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet. 1994 Aug;7(4):551. This article on PubMed

  10. Lussier-Cacan S, Xhignesse M, Piolot A. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996; 64: 587-593. This article on PubMed

  11. Tucker K, Selhub J, Wilson P, Rosenberg I. Dietary intake pattern relates to Plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 1996; 126: 3025-3031. This article on PubMed

  12. Ebesunun MO, Agbedana EO, Taylor GOL, Oladapo OO. Plasma lipoprotein (a), homocysteine and other cardiovascular disease(CVD) risk factors in Nigerians with established CVD. Appl Physiol Nutr Metab. 2008; 33: 282-289. This article on PubMed

  13. Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med. 2004 Jan 20;140(2):94-100. This article on PubMed

  14. Nygard O, Voiliset, SE, Refsum H, Stenvoid L, Tverdal A, Nordnehang JE. Total homocysteine and cardiovascular risk profile–the Hordland homocysteine study. JAMA. 1995; 274: 1526-33. This article on PubMed

  15. Quetelet LAJ. A treatise on man and the development of his faculties. In: Comparative statistics in the 19th century. Edinburgh, Scotland; William and Robert Chambers. 1842

  16. Allain CS, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20: 470-475. This article on PubMed

  17. Fossati P, Prencipi L. Serum Triglycerides determined colorimetrically with an enzyme that produces Hydrogen peroxide. Clin Chem. 1982; 28: 2077-2080. This article on PubMed

  18. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of Low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem. 1972; 18: 499-502. This article on PubMed

  19. Frantzer F, Faaren M, Atherm J, Nirdhil AK. Enzyme conversion immune assay for determination of total homocysteine in plasma or serum. Chin Chan. 1998; 44: 311 – 316

  20. Ware AG, Marbach EP. Determination of serum glucose by glucose oxidase. Clin Chem. 1968;14:548. This article on PubMed

  21. World Health Organization Diabetes action now; 1-18. World Health Organization World 2006; data base on body mass index: Classification of BMI. available at http://www.who.int/diabetes. Accessed 10 December 2011

  22. Stamler J, Vaccaro O, Neaton JD. Diabetes, other risk factors, and 12-yr Cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16: 434-444. This article on PubMed

  23. McAnulty SR, McAnulty LS, Nieman DC, Morrow JD, Shooter LA, Holmes S, Heward C, Henson DA. Effect of alpha-tocopherol supplementation on plasma homocysteine and oxidative stress in highly trained athletes before and after exhaustive exercise. J Nutr Biochem. 2005 Sep;16(9):530-7. This article on PubMed

  24. Howard, JK, Chambless VJ, Malinow LE, Pettigrew MR, Stampfer LC, Toole M. Vitamin intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology. 2001; 20:16-25. This article on PubMed

  25. Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr. 1998; 157(2): S71-S76. This article on PubMed

  26. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, and al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 1998 Nov 3;98(18):1848-52. This article on PubMed

  27. Olefsky JM, Farquhar JW, Reaven GM. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med. 1974 Oct;57(4):551-60. This article on PubMed